Design, synthesis, and antitumor evaluation of quinazoline-4-tetrahydroquinoline chemotypes as novel tubulin polymerization inhibitors targeting the colchicine site
- 6 December 2024
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 283, 117139
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82104018, 82473782, 82073318)
This publication has 37 references indexed in Scilit:
- Molecular interactions at the colchicine binding site in tubulin: An X-ray crystallography perspectiveDrug Discovery Today, 2021
- Application of ensemble pharmacophore-based virtual screening to the discovery of novel antimitotic tubulin inhibitorsComputational and Structural Biotechnology Journal, 2021
- Comprehensive Analysis of Binding Sites in TubulinAngewandte Chemie International Edition, 2021
- Recent developments in tubulin polymerization inhibitors: An overviewEuropean Journal of Medicinal Chemistry, 2014
- A phase 2 trial of verubulin for recurrent glioblastoma: a prospective study by the brain tumor investigational consortium (BTIC)Journal of Neuro-Oncology, 2014
- Novel 2-chloro-4-anilino-quinazoline derivatives as EGFR and VEGFR-2 dual inhibitorsEuropean Journal of Medicinal Chemistry, 2014
- N-Aryl-6-methoxy-1,2,3,4-tetrahydroquinolines: A novel class of antitumor agents targeting the colchicine site on tubulinEuropean Journal of Medicinal Chemistry, 2013
- Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiformeJournal of Neuro-Oncology, 2012
- An Overview of Tubulin Inhibitors That Interact with the Colchicine Binding SitePharmaceutical Research, 2012
- Microtubule dynamicsCellular and Molecular Life Sciences, 2001